---
schema_version: "secwatch.filing_event.v1"
accession: "0001411685-25-000081"
form_type: "8-K"
ticker: "VTGN"
cik: "0001411685"
company_name: "Vistagen Therapeutics, Inc."
filed_at: "2025-09-15T23:59:59+00:00"
generated_at: "2026-05-17T06:36:42.009853+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Vistagen CFO Cynthia Anderson resigns effective Oct 15; annual meeting votes ratified

## Summary
- CFO Cynthia L. Anderson resigns effective Oct 15, 2025; resignation not due to any disagreement with company.
- Company is searching for a successor; intends to enter a consulting agreement with Anderson for transition support.
- Six director nominees elected at annual meeting, including CEO Shawn Singh and Chair Margaret FitzPatrick.
- Non-binding advisory vote on executive compensation (say-on-pay) approved by stockholders.
- Appointment of KPMG as independent auditor for fiscal year ending March 31, 2026 ratified.

## SEC filing metadata
- accession: 0001411685-25-000081
- form_type: 8-K
- ticker: VTGN
- cik: 0001411685
- company_name: Vistagen Therapeutics, Inc.
- filed_at: 2025-09-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411685/000141168525000081/0001411685-25-000081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411685/000141168525000081/vtgn-20250909.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001411685-25-000081
- JSON: https://secwatch.observer/filing/0001411685-25-000081.json
- Plain text: https://secwatch.observer/filing/0001411685-25-000081.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.